Related Articles
The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer
Altered glutamate cysteine ligase expression and activity in renal cell carcinoma
Nuclear localization of glutamate-cysteine ligase is associated with proliferation in head and neck squamous cell carcinoma
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts